Replacement of. If the [*] cell line dies during the Term of this Agreement, FHCRC will, after it has been reimbursed its reasonable costs and expenses by LICENSEE, and no more than two occasions during the Term, provide to LICENSEE sufficient quantities of additional seed stock from the MWCB to replace the cell line, but in no event more then a total of two additional vials.
Appears in 1 contract
Sources: Non Exclusive License Agreement (Xcyte Therapies Inc)
Replacement of. If the [*] cell line dies during the Term of this Agreement, FHCRC will, after it has been reimbursed its reasonable costs and expenses by LICENSEE, and no more than two occasions during the Term, provide to LICENSEE sufficient quantities of additional seed stock from the MWCB to replace the cell line, but in no event more then a total of two additional vials.
Appears in 1 contract
Sources: Non Exclusive License Agreement (Xcyte Therapies Inc)